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Summary
Borrelia burgdorferi, the aetiological agent of Lyme
disease, follows a life cycle that involves passage
between the tick vector and the mammalian host. To
investigate the role of the 36 kb linear plasmid, lp36
(also designated the B. burgdorferi K plasmid), in
the infectious cycle of B. burgdorferi, we examined a
clone lacking this plasmid, but containing all other
plasmids known to be required for infectivity.
Our results indicated that lp36 was not required
for spirochete survival in the tick, but the clone
lacking lp36 demonstrated low infectivity in the
mammal. Restoration of lp36 to the mutant
strain conﬁrmed that the infectivity defect was due
to loss of lp36. Moreover, spirochetes lacking lp36
exhibited a nearly 4-log increase in ID50 relative to
the isogenic lp36+ clone. The infectivity defect of
lp36-minus spirochetes was localized, in part, to
loss of the bbk17 (adeC) gene, which encodes an
adenine deaminase. This work establishes a
vital role for lp36 in the infectious cycle of B. burg-
dorferi and identiﬁes the bbk17 gene as a compo-
nent of this plasmid that contributes to mammalian
infectivity.
Introduction
Borrelia burgdorferi, the aetiological agent of Lyme
disease, has an enzootic life cycle that requires persis-
tence in two disparate environments, the arthropod vector
and the mammalian host (Burgdorfer et al., 1982;
Donahueet al.,1987;Laneet al.,1991;Lane,1994).Inthe
wild, B. burgdorferi spirochetes cycle between small
mammals, such as the white-footed mouse, Peromyscus
leucopus, and Ixodes sp. ticks (Burgdorfer et al., 1982;
Donahue et al., 1987; Lane et al., 1991; Lane, 1994).
Humans, although not reservoirs for B. burgdorferi,m a y
become infected when fed upon by infected ticks. Survival
in nature of B. burgdorferi, an obligate parasite, entails: (i)
infectionofandpersistenceinthetick(ii)transmissionfrom
tick to mammal during a blood meal (iii) persistent infection
in the mammal and (iv) reacquisition from the mammal by
feedingticks(Steereet al.,1983;Steere,2001).Thedevel-
opment of tools for genetic manipulation of B. burgdorferi
has facilitated the identiﬁcation of molecular determinants
requiredforthesurvivalofthisspirochetethroughoutitslife
cycle (Rosa et al., 2005).
Borrelia burgdorferi harbours a segmented genome
that includes a small, 900 kb linear chromosome and as
many as 23 circular and linear plasmids, ranging in size
from 5 kb to 56 kb (Fraser et al., 1997; Stevenson et al.,
1997; 1998; Casjens et al., 2000; Miller et al., 2000).
Genome sequence analyses of B. burgdorferi type strain
B31 reveal that a majority of the plasmid-encoded open
reading frames have no database matches (Fraser et al.,
1997; Casjens et al., 2000). The B. burgdorferi genome is
unstable during in vitro passage and many of the plasmids
can be lost during this process. Loss of certain plasmids is
tightly correlated with loss of infectivity and persistence in
mice and ticks (Schwan et al., 1988a; Norris et al., 1995;
Xu et al., 1996; 2005; Purser and Norris, 2000;
Labandeira-Rey and Skare, 2001; McDowell et al., 2001;
Labandeira-Rey et al., 2003; Grimm et al., 2004; 2005;
Lawrenz et al., 2004; Strother et al., 2005), while not
affecting growth in vitro.
For example, the linear plasmid (lp) lp25 is critical for
infection of the mouse and tick (Purser and Norris, 2000;
Labandeira-Rey and Skare, 2001; Labandeira-Rey et al.,
2003; Grimm et al., 2004; 2005; Revel et al., 2005;
Strother et al., 2005) and linear plasmid lp28-1 is neces-
sary for persistence in the mouse (Zhang et al., 1997;
Accepted 13 April, 2007. *For correspondence. E-mail jewettm@
niaid.nih.gov; Tel. (+1) 406 363 9304; Fax (+1) 406 363 9394.
†Present address: IDEXX Laboratories, Westbrook, ME 04092,
USA.
Re-use of this article is permitted in accordance with the Creative
Commons Deed, Attribution 2.5, which does not permit commercial
exploitation.
Molecular Microbiology (2007) 64(5), 1358–1374 doi:10.1111/j.1365-2958.2007.05746.x
Journal compilation © 2007 Blackwell Publishing Ltd
No claim to original US government worksPurser and Norris, 2000; Labandeira-Rey and Skare,
2001; Labandeira-Rey et al., 2003; Grimm et al., 2004;
Revel et al., 2005; Xu et al., 2005). At least some of the
genetic elements present on lp25 that contribute to in vivo
survival have been identiﬁed. The pncA (bbe22) gene on
lp25 encodes a nicotinamidase, an enzyme that is suffi-
cienttorestoreinfectivityinmiceandtickstocloneslacking
the entire lp25 plasmid (Purser et al., 2003; Grimm et al.,
2005; Strother et al., 2005). In addition, lp25 harbours the
bptA (bbe16) gene that encodes a putative lipoprotein that
is important for persistence of B. burgdorferi in the tick
(Revel et al., 2005). The lp28-1 plasmid carries the vlsE
locus, which undergoes antigenic variation during mam-
malianinfectionandispresumedtoberequiredforevasion
of the host immune system and establishment of a persis-
tent infection (Zhang et al., 1997; Zhang and Norris, 1998;
Eicken et al., 2001; Indest et al., 2001; McDowell et al.,
2002; Ohnishi et al., 2003).
Unlike lp25 and lp28-1, the lp36 plasmid has rarely been
observed to be lost by B31 B. burgdorferi during in vitro
passage (Purser and Norris, 2000) and its potential role in
the B. burgdorferi infectious cycle has not been examined.
We have identiﬁed a low passage B31 clone that has lost
lp36,butharboursallotherplasmidsknowntobeimportant
for virulence, thereby allowing investigation of the role of
this plasmid in the B. burgdorferi infectious cycle.The lp36
plasmid of strain B31 is a linear plasmid of approximately
36 kb encoding 54 putative open reading frames, seven of
which appear to be pseudogenes (Fraser et al., 1997;
Casjens et al., 2000). Moreover, a majority of the genes
found on lp36 from strain B31 have no predicted function
(Casjens et al., 2000). Of the few genes on lp36 that have
a putative function (Casjens et al., 2000), bbk32 has been
shown to encode a ﬁbronectin binding protein (Probert and
Johnson, 1998; Parveen and Leong, 2000; Probert et al.,
2001) that may be involved in B. burgdorferi mammalian
infectivity (Li et al., 2006; Seshu et al., 2006). We found
that spirochetes lacking lp36 did not readily survive in the
mammal but displayed no deﬁciency in the tick. Mouse
infection was restored by reconstitution of the lp36 plasmid
in the mutant clone, demonstrating that the infectivity
defect resulted from the loss of lp36. Furthermore, we
established that the bbk17 gene of lp36 encodes an
adeninedeaminase(AdeC)andisageneticcomponenton
lp36 that contributes to mammalian infectivity and is suffi-
cient to restore mouse infectivity to spirochetes lacking
lp36. Our work establishes a critical role for the lp36
plasmid in the B. burgdorferi infectious cycle.
Results
Borrelia burgdorferi lacking lp36 are unable to establish
infection in a mouse by needle inoculation
To evaluate the ability of B. burgdorferi lacking lp36 to
adapt to and survive in the mammalian environment, we
took advantage of a derivative of the low passage clone
A3-M9 (Table 1) that lacks this plasmid, but contains all
other plasmids known to be required for infectivity
(Table 1). For direct experimental comparison, we reintro-
duced lp36 marked with a gentamicin resistance cassette
into the lp36-minus clone in order to obtain an isogenic
lp36+ clone (A3-M9 lp36-minus/lp36-gent) (Table 1). C3H/
HeN mice were inoculated at a target dose of 5 ¥ 103
spirochetes by a combination of intraperitoneal and sub-
cutaneous routes with A3-M9 lp36-minus or the isogenic
clone to which the lp36 plasmid was restored (A3-M9
lp36-minus/lp36-gent) (Table 2). Four weeks post inocula-
tion, the mice were bled and their sera were assessed for
reactivitywithB. burgdorferiantigens.Noneofthesixmice
inoculated with lp36-minus spirochetes showed evidence
of seroconversion, in contrast to the 14 out of 15 mice that
became infected with lp36+ spirochetes (Table 2, Fig. 1A).
Moreover, no lp36-minus spirochetes were isolated from
any of the mouse tissues examined (Table 2). Lp36+ spiro-
chetes were reisolated from all three tissue sources of
seropositive mice (Table 2). In vitro growth studies con-
ﬁrmed that lp36-minus spirochetes had no general growth
defect relative to lp36+ spirochetes. Both clones demon-
stratedadoublingtimeofapproximately5.4 handreached
a maximum stationary phase density of 4.0 ¥ 108 spiro-
chetes ml-1, eliminating the possibility that in vivo pheno-
typic differences were a consequence of in vitro growth
differences between the two clones. These data provided
theﬁrstdirectevidenceofacriticalroleforthelp36plasmid
in the ability of B. burgdorferi to colonize and establish a
persistent infection in a mouse.
Table 1. B. burgdorferi clones used in this study.
Clone Introduced DNA Plasmid(s) missing Reference
A3-M9 None cp9, lp21 Tilly et al. (2004)
A3-M9 lp36-minus None cp9, lp21, lp36 This work
A3/lp36-gent lp36 + ﬂaBp-aacC1 cp9 This work
A3-M9 lp36-minus/lp36-gent lp36 + ﬂaBp-aacC1 cp9, lp21 This work
A3-M9 lp36-minus/pBSV2G pBSV2G cp9, lp21, lp36 This work
A3-M9 lp36-minus/pBSV2G bbk17 pBSV2G bbk17 cp9, lp21, lp36 This work
A3-M9 Dbbk17::ﬂgBp-kan/pBSV2G Dbbk17::ﬂgBp-kan, pBSV2G cp9, lp21 This work
A3-M9 Dbbk17::ﬂgBp-kan/pBSV2G bbk17 Dbbk17::ﬂgBp-kan, pBSV2G bbk17 cp9, lp21 This work
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or survival within, Ixodes scapularis ticks
In addition to survival in the mammalian host, the B.
burgdorferi infectious cycle requires colonization and per-
sistent infection of the tick vector. Because spirochetes
lacking lp36 did not establish a mouse infection by needle
inoculation, we were unable to naturally infect ticks with
lp36-minus B. burgdorferi by directly feeding them on
infected mice. In lieu of this, cohorts of approximately 100
I. scapularis larvae were artiﬁcially infected with clone
A3-M9 lp36-minus or A3-M9 lp36-minus/lp36-gent by
immersion in borrelial cultures (Policastro and Schwan,
2003; Grimm et al., 2005). Seven days after feeding to
repletion on mice, larvae were assessed for the presence
and abundance of spirochetes in their midguts by immun-
oﬂuorescence assay (IFA) and plating of dilutions of tritu-
rated whole ticks in solid BSK medium. The B. burgdorferi
clones lacking or containing lp36 demonstrated equal
ability to infect larval ticks (10/10 and 16/16 respectively).
Furthermore, no difference in the average number of spi-
rochetes per larval tick was detected between the clones
following the blood meal (Fig. 2A, P > 0.05).
Asimilar proportion of ticks infected with the lp36-minus
or lp36+ B. burgdorferi clones (22/29 and 22/27 respec-
tively) retained spirochetes through the molt to nymphs,
indicating that spirochetes lacking lp36 do not demon-
strate reduced ﬁtness compared to lp36+ spirochetes.
Ticks that maintained Borrelia infections with either
clone through the molt harboured comparable spirochete
Table 2. Infection of mice with B. burgdorferi clones lacking or containing lp36.
a
Clone Serology
c
Reisolation from tissues
d
No. of mice
infected/total P-value
e Ear Bladder Joint
A3-M9 lp36-minus
b 0/6 0/6 0/6 0/6 0/6 0.0001
A3-M9 lp36-minus/lp36-gent
f 14/15 14/15 14/15 14/15 14/15
a. Mice were infected by needle inoculation with a target dose of 5 ¥ 10
3 spirochetes as described in the Experimental procedures.
b. Pooled data from two separate infection experiments.
c. Assessed by immunoblot analysis with cell lysates of B. burgdorferi and E. coli producing P39 recombinant protein at 3 and 6 weeks post
inoculation.
d. Mice were sacriﬁced and tissues harvested 6 weeks post inoculation.
e. The P-value was calculated by Fischer’s exact test for the number of infected mice in the two groups.
f. Pooled data from three separate infection experiments.
Fig. 1. Serological responses of mice infected with various clones of B. burgdorferi.
A. Immunoblot analysis of sera collected 6 weeks post inoculation from C3H/HeN mice injected with a target dose of 5 ¥ 10
3 spirochetes of
B. burgdorferi clones lacking or containing lp36. Protein lysates tested for seroreactivity include: E. coli, lysate of E. coli carrying a cloning
vector; E. coli + P39, lysate of E. coli carrying a cloning vector producing the B. burgdorferi P39 protein; Bb, lysate of B. burgdorferi.
Representative results with the serum of mice inoculated with each B. burgdorferi clone are shown. The position of the P39 protein is
indicated with an arrow to the right of the panel. The positions of markers to the left of the panel depict molecular weights in kilodaltons.
B. Immunoblot analysis of sera collected 7 weeks post tick feeding from RML mice fed on by either approximately 100 I. scapularis larvae or
approximately 20 I. scapularis nymphs infected with B. burgdorferi clones containing or lacking lp36. Protein lysates tested were as described
for A. The ﬁrst panel shows representative results obtained with the serum of mice fed on by larval or nymphal ticks infected with spirochetes
containing lp36. The second panel shows an example of results obtained with the serum from the two seropositive mice fed on by larval ticks
infected with spirochetes lacking lp36. The third panel shows an example of results obtained with the serum from the two seropositive mice
fed on by nymphal ticks infected with spirochetes lacking lp36. The position of the P39 protein is indicated with an arrow to the right of the
panel. The positions of markers to the left of the panel depict molecular weights in kilodaltons. Comparable serum dilutions and exposure
times were used for all blots.
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P > 0.05). These results indicate that the lp36 plasmid is
not required by B. burgdorferi for colonization of larval
ticks, replication of spirochetes within fed larvae, trans-
stadial persistence, or replication of spirochetes within
nymphs after tick feeding. Together our data suggest that
lp36 is required for B. burgdorferi survival in the mamma-
lian environment, but not in the tick environment.
Spirochetes lacking lp36 are attenuated for mouse
infection by tick bite
The lp36 plasmid had no effect on tick infection and equal
spirochete loads were detected in infected ticks following
the blood meal regardless of the presence or absence of
lp36 (Fig. 2). Therefore, we tested whether or not the mice
became infected with lp36-minus B. burgdorferi when fed
upon by infected ticks, thus representing the natural route
of mammalian infection. Unlike mice inoculated by
needle, RML mice fed on by larval ticks artiﬁcially infected
with B. burgdorferi cloneA3-M9 lp36-minus demonstrated
reduced, but detectable levels of infection (Table 3). Two
out of the ﬁve mice tested in three separate experiments
developed weak seroreactivity towards Borrelia antigens
(Fig. 1B, Table 3) and reisolation of lp36-minus spiro-
chetes was limited to the ear tissue of these mice
(Table 3). The absence of the lp36 plasmid in the ear
reisolates was conﬁrmed by Southern blot analysis (data
not shown). In contrast to the lp36-minus clone and con-
sistent with previous results by needle inoculation, four
out of ﬁve of the mice fed on by larval ticks artiﬁcially
infected with B. burgdorferi clone A3-M9 lp36-minus/lp36-
gent became infected (Table 3). Of those seropositive
mice, lp36+ spirochetes were reisolated from all tissues
examined (Table 3). Similar numbers of spirochetes were
detected in all larval ticks regardless of whether or not the
mice upon which they had fed became infected, suggest-
ing there was no difference in the inoculum received by
each mouse (Fig. 2 and data not shown).
Similar results were obtained after feeding infected
nymphs on mice. Weak seroreactivity towards Borrelia
antigens was detected in two out of the ﬁve mice fed upon
by lp36-minus-infected nymphs (Fig. 1B, Table 3). Lp36-
minus spirochetes were reisolated from the ear tissue and
the ear and bladder tissues of the two weakly seropositive
mice, respectively (Table 3). All of the four mice fed on by
nymphs infected with lp36+ spirochetes demonstrated
robust seroconversion and spirochetes were reisolated
from all three tissue sources (Table 3). As for larval ticks,
similar numbers of spirochetes were detected in all
nymphal ticks regardless of whether or not the mice upon
which they had fed became infected, suggesting there
was no difference in the inoculum received by each
mouse (Fig. 2 and data not shown).
The spirochete loads in tissues were assessed by
quantitative polymerase chain reaction (qPCR) of mice
infected by tick bite with spirochetes either lacking or
containing lp36. No difference in spirochete burden was
detected in the ear tissue of mice infected with either
clone (Fig. 3A). However, the joint and heart tissues from
mice infected with lp36+ spirochetes harboured a statisti-
cally greater bacterial load compared with those mice
infected with spirochetes lacking lp36 (Fig. 3A, P < 0.05).
Furthermore, the numbers of spirochetes in the joint and
heart tissues from mice infected with spirochetes lacking
lp36 were not different from that of uninfected tissues
(data not shown). These data were consistent with the
observation that reisolation of lp36-minus spirochetes
was mainly limited to the ear (Table 3).
Successful completion of the B. burgdorferi tick-mouse
infectious cycle requires the acquisition of spirochetes by
uninfected larval ticks while feeding on an infected
Fig. 2. Colonization of tick midguts by various B. burgdorferi clones
lacking or containing lp36.
A. I. scapularis larvae were artiﬁcially infected by immersion in
liquid cultures of B. burgdorferi clones and then fed to repletion on
naive mice. The number of spirochetes per larval tick was
quantiﬁed by plating of dilutions of triturated whole fed larvae in
solid BSK medium and determining colony-forming units.
Spirochete densities were determined 7 days post larval feeding to
repletion. Symbols represent the number of spirochetes per
individual fed larval tick.
B. Following the molt, nymphs were fed on uninfected mice and the
number of spirochetes per nymph was determined 7 and 14 days
post feeding to repletion as described in A. Symbols represent the
number of spirochetes per individual fed nymphal tick.
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lp36-minus and lp36+ B. burgdorferi to a limited number of
mice, we were now in a position to ask whether or not
uninfected larvae could acquire these spirochetes natu-
rally by feeding on infected mice, in order to complete
the infectious cycle. Approximately 100 uninfected
I. scapularis larvae were fed to repletion on mice infected
with either B. burgdorferi clone A3-M9 lp36-minus or
A3-M9 lp36-minus/lp36-gent. Larvae were assessed for
the presence and density of spirochetes in the midguts
7 days post feeding by IFA and plating of dilutions of
triturated whole ticks. No spirochetes were detected by
either IFA or plating of nine larvae that fed on mice
infected with spirochetes lacking lp36, while eight out of
nine of the larvae that fed on mice infected with lp36+
B. burgdorferi harboured live spirochetes.
There was no statistical difference in the absolute
number of mice that became infected by tick bite with
lp36-minus compared with lp36+ B. burgdorferi (Table 3).
Because there was evidence that the number of infected
tissues was reduced in mice infected with spirochetes
lacking lp36 compared with mice infected with lp36+ spi-
rochetes, the data were also compared using an exact
permutation test, which took into account the average
number of infected tissues per mouse. The P-values for
the difference between the number of infected tissues per
mouse infected with lp36-minus or lp36-minus/lp36-gent
spirochetes by larval or nymphal tick bite were 0.05 and
0.02 respectively. Although there was little to no lp36-
dependent statistical difference in mouse infection by tick
bite, there was a trend towards a difference that was not
detectable given the small sample size. Moreover, there
was a biological difference between the mice infected by
tick bite with lp36-minus compared to lp36+ spirochetes.
The serological response to Borrelia proteins of mice
infected with lp36-minus spirochetes was reduced relative
to mice infected with lp36+ spirochetes (Fig. 1B), lp36-
minus spirochetes were reisolated from limited tissues
(Table 3), and were only detected in the ear tissue by
qPCR (Fig. 3A). Finally, although a proportion of the mice
fed on by ticks infected with lp36-minus spirochetes
became infected, uninfected larvae did not acquire
lp36-minus spirochetes by feeding on these mice, demon-
strating that this infection does not permit efficient main-
tenance of B. burgdorferi in the infectious cycle.
Borrelia burgdorferi lacking lp36 are highly attenuated
relative to isogenic lp36+ spirochetes
Our results demonstrate that the lp36 plasmid is essential
for mouse infection by needle inoculation at a target dose
of 5 ¥ 103 spirochetes and important for wild-type levels of
mouse infectivity by tick bite. As the number of spiro-
chetes transmitted by an infected tick is undeﬁned and not
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fying the difference in the infectious capabilities of
B. burgdorferi lacking or carrying the lp36 plasmid by
determination of the 50% infectious dose (ID50) of these
clones by mouse needle inoculation.
Groups of C3H/HeN mice were challenged with
10-fold increasing doses of spirochetes. Four weeks
post inoculation, mouse infection status was determined
by reisolation of spirochetes from mouse tissues
(Table S1) and serological analysis (data not shown),
which correlated completely. Reisolation of lp36-minus
spirochetes from infected mice was limited to the ear
tissue (Table S1). Spirochetes were reisolated from all
three tissues of mice infected with lp36+ bacteria
(Table S1). Spirochetal load was assessed in the ear
and heart tissues of mice infected with 1 ¥ 107 and
1 ¥ 108 lp36-minus or lp36+ spirochetes. These two
inocula were chosen for analysis of the spirochete
burden in infected mouse tissues because it was at
these doses that the greatest number of mice became
infected with spirochetes lacking lp36, although only two
mice were inoculated with lp36+ spirochetes at each of
these doses (Table S1). Spirochete burdens in the ear
and heart tissues of mice infected with both 1 ¥ 107 and
1 ¥ 108 spirochetes were dependent on the presence of
lp36 (Fig. 3B, P < 0.05). Furthermore, the numbers of
spirochetes in the heart tissue from mice infected with
spirochetes lacking lp36 were no different from that of
uninfected tissues (data not shown).
The dose–response curve for A3-M9 lp36-minus dem-
onstrated a statistically signiﬁcant right shift (P < 0.05)
relative to the dose–response curve for A3-M9 lp36-
minus/lp36-gent (Fig. 4). The ID50 for A3-M9 lp36-minus
was estimated to be 7.1 ¥ 106 [95% conﬁdence interval
(CI): 1.1 ¥ 106 - 5.8 ¥ 107] spirochetes compared with
9.5 ¥ 102 (95% CI: 1.5 ¥ 102 - 5.0 ¥ 103) spirochetes for
A3-M9 lp36-minus/lp36-gent (Table S1). The ID50 value of
9.5 ¥ 102 for lp36+ spirochetes is similar to previously
reported ID50 values for other B31-derived low passage,
infectious B. burgdorferi clones (Tilly et al., 2006).
Together these data indicate that B. burgdorferi lacking
lp36 demonstrate an almost 4-log increase in ID50 relative
Fig. 3. Quantitative assessment of spirochetal loads in infected
mouse tissues.
A. DNA was isolated from ear, heart and joint tissues from a subset
of RML mice that were reisolation-positive 7 weeks post feeding by
larval or nymphal ticks infected with lp36-minus ( lp36
-)o r
lp36-minus/lp36-gent ( lp36–/lp36+) spirochetes. Samples were
assessed for spirochete ﬂaB and murine nidogen DNA copies by
qPCR. The data are expressed as ﬂaB copies per 1000 nidogen
copies. Each data point represents the average of triplicate
measures from the tissue DNA of an individual mouse.
B. DNA was isolated from ear and heart tissues (joint tissue was
not available from these experiments) from C3H/HeN mice that
were reisolation-positive 4 weeks post inoculation with 1 ¥ 10
7 or
1 ¥ 10
8 lp36-minus ( lp36
-) or lp36-minus/lp36-gent (
lp36–/lp36+) spirochetes. Data shown are pooled data from
individual mice inoculated with either 1 ¥ 10
7 or 1 ¥ 10
8 spirochetes.
The data were collected and presented as described in A.
C. DNA was isolated from ear, joint and heart tissues from
C3H/HeN mice that were reisolation positive 6 weeks post
inoculation with 5 ¥ 10
3 lp36-minus/pBSV2G bbk17 (∇
lp36
-/pBSV2G bbk17) or lp36-minus/lp36-gent ( lp36–/lp36+)
spirochetes. The data were collected and presented as described
in A.
D. DNA was isolated from ear and heart tissues (joint tissue was
not available from these experiments) from C3H/HeN mice that
were reisolation-positive 4 weeks post inoculation with 1 ¥ 10
4
Dbbk17/pBSV2G ()o rDbbk17/pBSV2G bbk17 () spirochetes.
The data were collected and presented as described in A.
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of this plasmid in mammalian infectivity.
The bbk17 gene is a component of lp36 that contributes
to mammalian infectivity
Our data have established that the lp36 plasmid is not
required for infection and survival within the tick vector, but
is critical for infection of the mammalian host. There are 56
putative open reading frames on lp36, most of which
encode hypothetical proteins with no similarity to proteins
of known function (Fraser et al., 1997; Casjens et al.,
2000). Previous studies debate the in vivo importance of
the lp36 gene bbk32, which encodes a ﬁbronectin-binding
protein (Probert and Johnson, 1998; Parveen and Leong,
2000; Probert et al., 2001). These earlier studies demon-
strated either a single log increase in the infectious dose of
the mutant compared with the complemented clone
(1.8 ¥ 103 and 80 spirochetes respectively) (Seshu et al.,
2006), or no difference in the ability of the mutant to infect
and survive in the mouse at a dose of 105 spirochetes (Li
et al., 2006), suggesting that additional genes on lp36 are
required for mammalian infectivity. The lp36 open reading
frame BBK17 encodes a putative adenine deaminase, an
enzyme involved in the conversion of adenine to hypoxan-
thine that is important for purine salvage in numerous
bacteria and lower eukaryotes (Nygaard et al., 1996).
Giventhesigniﬁcanceofthisenzymeformicrobialmetabo-
lism of purine nucleotides and nucleosides, and the appar-
ent inability of B. burgdorferi to synthesize purines de novo
(Fraser et al., 1997; Casjens et al., 2000), we hypoth-
esized that the bbk17 gene might contribute to the survival
of B. burgdorferi in the mammalian environment.
To examine the ability of the bbk17 gene alone to restore
infectivity to spirochetes lacking the lp36 plasmid, clone
A3-M9 lp36-minus was transformed with either a Borrelia
shuttle vector harbouring the bbk17 gene (pBSV2G
bbk17) or pBSV2G alone. Infectious phenotypes of the
resulting isogenic clones were examined by a combination
of intraperitoneal and subcutaneous needle inoculation of
a target dose of 5 ¥ 103 spirochetes into a total of 15
C3H/HeN mice in three separate experiments (Table 4).
As previously established, spirochetes lacking the entire
lp36 plasmid were severely impaired in their ability to
survive in the mammalian host, because only one out of 15
mice was infected with clone A3-M9 lp36-minus/pBSV2G
(Table 4). Strikingly, all 15 mice inoculated with lp36-minus
spirochetes harbouring pBSV2G bbk17 became infected,
as determined by a strong antibody response to Borrelia
antigens and reisolation of spirochetes from all three
mouse tissues (Table 4). ID50 analysis conﬁrmed the ability
of the bbk17 gene to restore wild-type infectivity to spiro-
chetes lacking lp36. The dose–response curve for clone
A3-M9 lp36-minus/pBSV2G bbk17 was not statistically
different from that of lp36+ spirochetes (P > 0.05) (Fig. 4).
The ID50 for this clone was estimated to be 4.1 ¥ 102 (95%
CI: 5.5 ¥ 101 - 2.1 ¥ 103) spirochetes (Table S1), which
was similar to that determined for spirochetes harbouring
the lp36 plasmid and 4 logs less than the ID50 for spiro-
chetes lacking lp36 (Table S1). Because reintroduction of
bbk17 to B. burgdorferi lacking lp36 restored the ID50 to
that of lp36+ spirochetes, the spirochetal load in tissues
was assessed to determine whether reintroduction of the
bbk17 gene alone to B. burgdorferi lacking lp36 resulted in
a spirochete burden comparable to mice infected with
lp36+ B. burgdorferi. Similar spirochetal loads were
detected in the ear and joint tissues of mice infected with
lp36-minus/pBSV2G bbk17 and lp36+ spirochetes
(Fig. 3C, P > 0.05). However, a statistically greater
number of bacteria were present in the heart tissue of mice
Fig. 4. ID50 analysis of B. burgdorferi clones.
Probit regression on adjusted spirochete
doses was used to estimate the ID50 of
B. burgdorferi clones. The plot represents the
probability of infection versus the base 10
logarithm of the adjusted dose. Mouse
infection data from both the ID50 and single
dose experiments were included. Actual
doses of the different inocula were adjusted
for both the observed colony-forming units
following plating on solid medium and the
proportion of the B. burgdorferi population
harbouring both lp25 and lp28-1. The point
size is proportional to the number of mice
inoculated at different target doses.
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bouring the bbk17 gene alone (Fig. 3C, P < 0.001). These
data suggest that although reintroduction of the bbk17
gene alone appears to be sufficient to restore mammalian
infectivity to spirochetes lacking the entire lp36 plasmid, as
measured by serology, spirochete reisolation from tissues
and ID50, these spirochetes may be impaired for dissemi-
nation to deeper tissues such as the heart. Dissemination
of this clone may be limited due to the absence of addi-
tional genes on lp36 (Terekhova et al., 2006), such as
bbk32.
Inactivation of bbk17 attenuates B. burgdorferi infection
in mice
Because addition of the bbk17 gene alone restored infec-
tivity to spirochetes lacking lp36, this gene should be
required for the ability of B. burgdorferi to infect the mam-
malian host. In order to test this hypothesis, we deleted
the bbk17 gene from the wild-type infectious clone A3-M9
and transformed the mutant with either the empty shuttle
vector, pBSV2G (Elias et al., 2003) or with the shuttle
vector containing bbk17, pBSV2G bbk17. Deletion
of the bbk17 gene had no effect on spirochetal growth
in vitro (data not shown). The infectious phenotype of
B. burgdorferi lacking only the bbk17 gene (Dbbk17)w a s
assessed by a combination of intraperitoneal and subcu-
taneous needle inoculation of a target dose of 5 ¥ 103
spirochetes into a total of 15 C3H/HeN mice per clone in
three experiments. Serological analysis of mice infected
with Dbbk17 spirochetes demonstrated a weak antibody
response limited to the Borrelia antigen P39 (Simpson
et al., 1991) in only one out of the 15 mice inoculated
(Table 4 and data not shown). Reisolation of Dbbk17 spi-
rochetes was limited to the joint tissue of the single weakly
seropositive mouse (Table 4). In contrast, the isogenic
clone complemented with the bbk17 gene on pBSV2G
(bbk17 +) elicited strong seroreactivity towards all Borrelia
antigens in 13 out of the 15 mice inoculated, and bbk17 +
spirochetes were reisolated from all three tissue sources
(Table 4). These data suggest that the bbk17 gene is a
component of lp36 that contributes signiﬁcantly to the
critical role of this plasmid in mouse infectivity.
Analysis of the 50% infectious dose of Dbbk17 and
bbk17 + spirochetes demonstrated a statistically signiﬁ-
cant right shift (P = 0.015) in the dose–response curve for
the Dbbk17 clone relative to its isogenic complement
(Fig. 4), indicating a bbk17-dependent signiﬁcant differ-
ence in mouse infectivity. However, this only represented
an approximate 10-fold increase in the ID50 for
B. burgdorferi lacking the bbk17 gene compared with the
complemented clone, which were estimated to be
8.5 ¥ 103 (95% CI: 1.8 ¥ 103 - 4.6 ¥ 104) and 6.6 ¥ 102
(95% CI: 9.3 ¥ 101 - 3.3 ¥ 103) spirochetes, respectively
(Table S1), and not the 4-log increase in ID50 observed for
spirochetes lacking the entire lp36 plasmid. Furthermore,
no differences in spirochetal loads in ear and heart tissues
were detected between infected mice inoculated with
1 ¥ 104 Dbbk17 or bbk17 + spirochetes (Fig. 3D, P > 0.05),
suggesting that once mice become infected with either of
these clones, there is no bbk17-dependent difference in
spirochete burden among tissues. Although deletion of
bbk17 resulted in an increase in ID50 compared with the
isogenic complement, additional genes on lp36 may be
required for mouse infectivity. Together these data
suggest that the bbk17 gene is one of several genes on
lp36 that contribute, in a dose-dependent manner, to
mouse infection by B. burgdorferi. This result was unan-
ticipated given the previous observation that addition of
bbk17 alone to spirochetes lacking the entire lp36 plasmid
restored mouse infectivity.
The bbk17 gene encodes an adenine deaminase
The bbk17 gene encodes a 548 amino acid protein that
shares 33% and 31% amino acid identity with the adenine
deaminase enzymes (AdeC) from Bacillus subtilis
and Escherichia coli, respectively (Nygaard et al., 1996;
Table 4. Infection of mice with B. burgdorferi clones lacking or containing bbk17.
a
Clone Serology
b
Reisolation from tissues
c
No. of mice
infected/total P-value
d Ear Bladder Joint
A3-M9 lp36-minus/pBSV2G 1/15 1/15 0/15 0/15 1/15 < 0.0001
A3-M9 lp36-minus/pBSV2G bbk17 15/15 15/15 15/15 15/15 15/15
A3-M9 Dbbk17::ﬂgBp-kan/pBSV2G 1/15 0/15 0/15 1/15 1/15 < 0.0001
A3-M9 Dbbk17::ﬂgBp-kan/pBSV2G bbk17 13/15 13/15 13/15 13/15 13/15
a. Mice were infected by needle inoculation with 5 ¥ 10
3 spirochetes as described in the Experimental procedures. Data shown are pooled from
three separate infection experiments.
b. Assessed by immunoblot analysis with cell lysates of B. burgdorferi and E. coli producing P39 recombinant protein at 3 and 6 weeks post
inoculation.
c. Mice were sacriﬁced and tissues harvested 6 weeks post inoculation.
d. The P-value was calculated by Fischer’s exact test for the number of infected mice in the two groups.
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hydrolase super family of metal-dependent hydrolases,
pfam01979 (Marchler-Bauer et al., 2005) and harbours
two conserved domains, cd01295 and COG1001, charac-
teristic of adenine deaminase enzymes (Marchler-Bauer
et al., 2005).
Adenine deaminase (EC 3.5.4.2) is required for the
direct deamination of adenine to produce hypoxanthine
and is important for the salvage and metabolism of
adenine in many prokaryotic species (Nygaard et al.,
1996). The putative enzymatic function of the bbk17
gene product was examined by quantifying the rate of
hypoxanthine production from adenine over 30 min,
using equivalent amounts of cell lysates made from
B. burgdorferi clones containing or lacking the bbk17
gene. All four B. burgdorferi clones harbouring the bbk17
gene (wild-type A3-M9, lp36-minus/lp36-gent, lp36-
minus/pBSV2G bbk17 and Dbbk17::ﬂgBp-kan/pBSV2G
bbk17) demonstrated adenine deaminase activity as
measured by an HPLC assay for hypoxanthine production
(Fig. 5, Table 5). A peak corresponding to the retention
time of hypoxanthine was detected in the bbk17 + lysates
using the reaction conditions described in the Experimen-
tal procedures (Fig. 5A). The identity of the hypoxanthine
product was conﬁrmed by the absence of this peak
in equivalent samples treated with xanthine oxidase
(EC 1.1.3.22) (Fig. 5B), an enzyme that degrades hypo-
xanthine to xanthine and ﬁnally to uric acid. No increase
in hypoxanthine production was detected over the
30 min reaction time in the assay of cell lysates lacking
the bbk17 gene (lp36-minus, lp36-minus/pBSV2G and
Dbbk17::ﬂgBp-kan/pBSV2G) (Fig. 5C, Table 5), indicating
that the enzymatic activity necessary for conversion of
adenine to hypoxanthine requires the bbk17 gene
product. Taken together, these data demonstrate that
the bbk17 gene encodes a protein with adenine deami-
nase activity and is appropriately annotated in the
B. burgdorferi genome as adeC (Fraser et al., 1997;
Casjens et al., 2000).
Discussion
In some cases B. burgdorferi plasmid loss has been
shown to correlate with in vivo attenuation while having no
effect on in vitro phenotypes. It is well established that
linear plasmids lp25 and lp28-1 are required for
B. burgdorferi survival in the mouse and/or the tick
(Schwan et al., 1988a; Norris et al., 1995; Xu et al., 1996;
2005; Purser and Norris, 2000; Labandeira-Rey and
Skare, 2001; McDowell et al., 2001; Labandeira-Rey
et al., 2003; Grimm et al., 2004; 2005; Lawrenz et al.,
2004; Strother et al., 2005). We have demonstrated that
yet another linear plasmid, lp36, is critical for
B. burgdorferi mouse infectivity.
Fig. 5. HPLC chromatograms of adenine deaminase enzyme
assays from B. burgdorferi cell lysates containing or lacking bbk17.
A. A representative chromatogram for a cell lysate of wild-type
clone A3-M9 30 min after the addition of 0.3 mM adenine (+bbk17,
–xanthine oxidase treatment). Excess adenine was detected as a
peak at a retention time of 6.3 min, identical to that of the adenine
standard (data not shown). Hypoxanthine production was detected
as a peak at a retention time of 4.7 min, identical to that of the
hypoxanthine standard (data not shown). Peak retention times are
shown in minutes along the x-axis.
B. No peak at a retention time consistent with hypoxanthine was
detected in an identical A3-M9 cell lysate sample 30 min after
the addition of 0.3 mM adenine treated with xanthine oxidase
(+bbk17, +xanthine oxidase treatment), as indicated by an arrow.
C. A representative chromatogram for a cell lysate of clone A3-M9
Dbbk17::ﬂgp-kan/pBSV2G 30 min after the addition of 0.3 mM
adenine (Dbbk17, –xanthine oxidase treatment). No peak at a
retention time consistent with hypoxanthine was detected in the
sample lacking the bbk17 gene, as indicated by an arrow.
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In vivo phenotypic comparison between a strain B31-
derived B. burgdorferi clone lacking lp36 and an isogenic
clone harbouring the lp36 plasmid demonstrated that
lp36-minus spirochetes are attenuated for maximal
mouse infectivity when administered by needle inocula-
tion, as well as by Ixodes larval and nymphal tick bite
(Tables 2 and 3, Fig. 1), but have no defect at any stage of
Ixodes tick infection (Fig. 2). A high inoculum of lp36-
minus B. burgdorferi (> 106 spirochetes) was required
for consistent mouse infection by needle inoculation
(Table S1). The number of spirochetes transmitted to mice
by infected ticks is undeﬁned, but some of the mice fed on
by ticks carrying lp36-minus B. burgdorferi became
infected (Table 3). The ability of tick transmitted spiro-
chetes to infect a mouse may depend on the presence of
tick-speciﬁc factors found in the saliva of the tick (Ribeiro,
1987; Ribeiro et al., 1987; 1990; Das et al., 2001; Zeidner
et al., 2002; Montgomery et al., 2004; Ramamoorthi et al.,
2005). In addition to the size of the inoculum and
tick salivary components, the phenotypic state of
B. burgdorferi transmitted from infected ticks relative to
that of needle-injected, in vitro grown spirochetes
(Schwan et al., 1995; Carroll et al., 1999; Ohnishi et al.,
2001; Revel et al., 2002; Ojaimi et al., 2003; Ramamoor-
thi et al., 2005) could also contribute to the infectious
capability of Borrelia.
The tissue source of the lp36-minus spirochetes infre-
quently reisolated from infected mice was mainly limited to
the mouse ear (Table 3, Table S1). In addition, quantita-
tive assessment of spirochetes in tissues of lp36-minus
infected mice indicated that spirochetes were limited to
ear tissue (Fig. 3Aand B). Reduced reisolation and detec-
tion by qPCR of lp36-minus spirochetes from deeper
mouse tissues, such as the bladder, joint and heart, may
suggest that these spirochetes are less able to survive in
those tissue microenvironments or that the Borreliae were
less able to disseminate to these sites. Despite weak
infection of a subset of mice fed on by ticks infected
with lp36-minus spirochetes, uninfected ticks that fed on
these mice did not acquire spirochetes, indicating that
B. burgdorferi lacking lp36 would not be effectively main-
tained in the infectious cycle. Furthermore, the ID50 value
for lp36-minus spirochetes was increased by almost 4-log
relative to lp36+ bacteria (Table S1). This level of attenu-
ation is similar to that of B. burgdorferi clones lacking the
essential virulence plasmids lp25 and lp28-1, the ID50
values for which have been determined to be greater than
107 and 105 spirochetes, respectively (Labandeira-Rey
and Skare, 2001; Purser et al., 2003). Together these data
indicate that like lp25 and lp28-1, lp36 is vital for
B. burgdorferi survival and persistence in the mammalian
environment.
The bbk17 gene encodes an adenine deaminase and is
important for B. burgdorferi survival in the mammalian
environment
BBK17 is appropriately annotated in the B. burgdorferi
genome as an adenine deaminase (AdeC) (Fraser et al.,
1997; Casjens et al., 2000). Enzymatic conversion of
adenine to hypoxanthine was detected in wild-type
B. burgdorferi protein lysates (Fig. 5, Table 5).This activity
could be attributed to the bbk17 gene product because
deletion of the entire lp36 plasmid, as well as deletion of
the bbk17 gene alone, resulted in loss of hypoxanthine
production (Fig. 5, Table 5). Moreover, reconstitution of
lp36 and complementation of the bbk17 defect restored
adenine deaminase activity (Table 5). B. burgdorferi does
not harbour the genes encoding enzymes known to be
required for de novo nucleotide/nucleoside biosynthesis
and therefore presumably scavenges purines and pyri-
madines from the host environment (Fraser et al., 1997;
Casjens et al., 2000). Because of the putative biochemical
function of the bbk17 gene product, mutant clones lacking
Table 5. Adenine deaminase activity of
B. burgdorferi clones.
Clone
Adenine deaminase activity
a
(pmol min
-1 mg
-1 total cell lysate  SD)
A3-M9 17  2.9
A3-M9 lp36-minus -0.4  0.7
b
A3-M9 lp36-minus/lp36-gent 19  0.2
A3-M9 lp36-minus/pBSV2G -0.1  0.6
b
A3-M9 lp36-minus/pBSV2G bbk17 8.5  0.2
A3-M9 Dbbk17::ﬂgBp-kan/pBSV2G -0.2  0.5
b
A3-M9 Dbbk17::ﬂgBp-kan/pBSV2G bbk17 15  2.4
a. Adenine deaminase activity was determined by the rate of hypoxanthine produced over a
30 min period and expressed as the average change in hypoxanthine per minute per milligram
of total protein in the cell lysate. Data represent the average of three experiments. Error is show
as the standard deviation (SD) from the mean.
b. No adenine deaminase activity was detected. A negative rate of hypoxanthine production
was observed as a result of consumption of background levels of hypoxanthine by unidentiﬁed
enzymatic activities present in the cell lysates.
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low in adenine and hypoxanthine. Spirochetes lacking the
lp36 plasmid or the bbk17 gene alone demonstrated no
defect in growth in vitro (data not shown). However, BSK II
is a complex, rich medium containing signiﬁcant levels of
free nucleotides, nucleosides and bases available for
direct transport that may bypass Borrelia’s requirement for
conversion of adenine to hypoxanthine. Similarly, the high
concentration of hypoxanthine in blood (Hartwick et al.,
1979), along with the availability of free nucleotides from
lysed cells in the blood meal, may bypass the requirement
for adenine de-aminase activity for survival of spirochetes
in the tick midgut. While B. burgdorferi may be able to use
the hypoxanthine in blood directly, in lieu of conversion of
adenine to hypoxanthine, these spirochetes are only tran-
siently present in the mammalian blood stream during
dissemination to various tissues and do not replicate to
high numbers in this microenvironment (Barthold et al.,
1992; Wormser, 2006). It is in the tissues that B. burgdor-
feri replicates and causes a persistent infection in the
mouse (Schwan et al., 1988b). Hypoxanthine appears to
have a limited tissue distribution relative to adenine, which
appears to be ubiquitous among mammalian tissues
(Wishart et al., 2007). Therefore, the mammalian environ-
ment may present more of a challenge to B. burgdorferi for
survival and may require AdeC for purine scavenge and
biosynthesis. Consistent with this hypothesis, mutations in
purine biosynthetic genes of various pathogenic bacterial
species have resulted in a loss of virulence in animal
models (Cersini et al., 2003; Alcantara et al., 2004;
Pechous et al., 2006; Pilatz et al., 2006).
The mammalian infectivity defect of B. burgdorferi
lacking the lp36 plasmid was indeed localized, in part, to
the bbk17 gene. Reintroduction of this gene alone under
the control of its own promoter eliminated the lp36-
dependent infectivity defect, although reduced spirochetal
loads were detected in the heart tissue of infected mice
compared that of mice infected with spirochetes harbour-
ing the entire lp36 plasmid. These data suggest that in the
absence of all other lp36 genes, addition of bbk17 is
sufficient for survival and persistence of B. burgdorferi in
the mouse, although additional genes on lp36, such as
bbk32, may be important to achieve maximum spirochetal
loads in all tissues.
In vivo analysis of B. burgdorferi lacking just the bbk17
gene at the target dose of 5 ¥ 103 spirochetes resulted in
infection of only one out of 15 mice (Table 4). This
attenuation was due to the absence of the bbk17 gene,
as complementation resulted in infection of 13 out of 15
mice (Table 4). ID50 analysis comparing Dbbk17 and
bbk17 + spirochetes only resulted in an approximate
10-fold difference in the ID50 values (Fig. 4, Table S1).
These results were unexpected given the striking attenu-
ation of spirochetes lacking bbk17 at a dose of 5 ¥ 103
spirochetes, as well as the ability of the bbk17 gene
alone to restore mouse infectivity to spirochetes lacking
the entire lp36 plasmid. The adenine deaminase activity
of the bbk17 gene may provide a survival advantage for
B. burgdorferi in this infection model; however, additional
genes present on lp36 appear to also contribute to
B. burgdorferi colonization and survival within the
mouse. Furthermore, the role of bbk17 in mouse infec-
tivity appears to be affected signiﬁcantly by relatively
small differences in the dose of the inoculum. Similarly,
deletion of the bbk32 gene, also encoded on lp36,
results in an approximate 10-fold increase in ID50 relative
to the complemented strain (1.8 ¥ 103 and 80 spiro-
chetes respectively) (Seshu et al., 2006); whereas
Dbbk32 B. burgdorferi established infections in all mice
inoculated with 1 ¥ 105 spirochetes (Li et al., 2006).
These data suggest that both the bbk17 and bbk32
genes, perhaps along with additional lp36 genes, are
important for colonization, dissemination and persistence
of B. burgdorferi in the mammalian environment.
Conclusion
Functions encoded by lp36 are critical for B. burgdorferi
mammalian infectivity. The importance of lp36 provides
additional support to the conclusion that genes vital to the
survival of B. burgdorferi in vivo can be located on plas-
mids (Schwan et al., 1988a; Norris et al., 1995; Xu et al.,
1996; 2005; Purser and Norris, 2000; Labandeira-Rey
and Skare, 2001; McDowell et al., 2001; Labandeira-Rey
et al., 2003; Byram et al., 2004; Grimm et al., 2004; 2005;
Lawrenz et al., 2004; Strother et al., 2005). This is an
unusual feature of the Borrelia genome, as plasmids of
other bacterial species typically carry non-essential genes
that confer a selective advantage in a particular
environment. The bbk17 gene has been identiﬁed as a
component of lp36 that contributes to the essential nature
of this plasmid by fulﬁlling a biochemical function impor-
tant for B. burgdorferi survival, thereby providing greater
insight into the genetic basis for the complex lifestyle of
B. burgdorferi.
Experimental procedures
Borrelia burgdorferi clones and growth conditions
All low-passage infectious B. burgdorferi clones used in this
study are listed in Table 1 and are derived from strain B31
clone A3, which lacks the plasmid cp9 but contains all 20
additional plasmids described in the parental strain MI-B31
(Elias et al., 2002). Wild-type clone A3-M9 was derived by
passage of A3 through a mouse, followed by single colony
isolation (Tilly et al., 2004). A3-M9 lacks both cp9 and lp21,
which have been demonstrated to be dispensable for mouse
and tick infection (Purser and Norris, 2000; Elias et al., 2002;
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parent clone A3-M9 that lost lp36 during outgrowth from a
frozen stock. B. burgdorferi were grown in liquid Barbour-
Stoenner-Kelly (BSK) II medium supplemented with gelatin
and 6% rabbit serum (Barbour, 1984) and plated in solid BSK
medium as previously described (Rosa and Hogan, 1992;
Samuels, 1995). All cultures were grown at 35°C with 2.5%
CO2. Kanamycin was used at 200 mgm l
-1 and gentamicin at
40 mgm l
-1.
Construction and restoration of lp36-gent
Plasmid lp36-gent was constructed by allelic exchange with a
1.8 kb fragment of lp36 encompassing the intergenic region
between ORFs K04 and K05 (position 3590–5424) harbour-
ing the ﬂaBp-aacC1 gentamicin resistance cassette inserted
into the BamHI site at position 4554 on lp36. All restriction
enzymes were purchased from New England Biolabs. Use of
the BamHI site on lp36 required the removal of the BamHI
site from the cloning vector pOK12 (Vieira and Messing,
1991) by restriction digestion of pOK12 with EcoRV and StuI,
followed by religation. The 1.8 kb fragment spanning nucle-
otides 3590–5424 of lp36 was ampliﬁed from B31 clone A3
genomic DNA using primers 1 and 2 (Table S2) and cloned
into pGEM-T easy (Promega). The lp36 DNA fragment was
removed from pGEM-T easy by restriction digestion with NotI.
The resulting DNA fragment was ligated into NotI-digested
pOK12 lacking BamHI. The ﬂaBp-aacC1 gentamicin resis-
tance cassette (Elias et al., 2003) was ampliﬁed using
primers 3 and 4 (Table S2) and cloned into pCR2.1-TOPO
(Invitrogen). The gentamicin resistance cassette was
removed from pCR2.1-TOPO by restriction digestion with
BamHI and ligated into the BamHI site within the 1.8 kb DNA
fragment of lp36 cloned into pOK12 lacking BamHI. The
structure of pOK12-lp36-gent was conﬁrmed by sequence
analysis. 20 mg of pOK12-lp36-gent plasmid DNA puriﬁed
from E. coli was transformed into B31 clone A3 as previously
described (Samuels, 1995; Elias et al., 2002; Grimm et al.,
2004) and transformants selected on solid BSK medium con-
taining gentamicin. Colonies were screened by PCR for the
presence of the gentamicin cassette on lp36 using primers 1
and 2 (Table S2). To restore lp36 to clone A3-M9 lp36-minus,
total plasmid DNA was puriﬁed from A3/lp36-gent and trans-
formed intoA3-M9 lp36-minus. Gentamicin-resistant colonies
were screened by PCR for the presence of the antibiotic
marker on lp36 using primers 1 and 2 (Table S2). Total
genomic DNA was prepared from lp36-gent PCR positive
clones and screened with a panel of primers for the presence
of all B. burgdorferi plasmids (Elias et al., 2002). A clone that
retained the B. burgdorferi plasmid content of the parent
clone was used in further experiments (Table 1). Restoration
of lp36 was further conﬁrmed by Southern hybridization (data
not shown).
Deletion of bbk17
The bbk17 gene was deleted from lp36 by allelic exchange
with the kanamycin resistance cassette, ﬂgBp-kan (Bono
et al., 2000). A 2.9 kb fragment including bbk17, 600 bp of
upstream sequence and 500 bp of downstream sequence
was ampliﬁed from B31 clone A3 genomic DNA using the
Expand Long PCR system (Roche) and primers 5 and 6
(Table S2) and cloned into pCR-XLTOPO (Invitrogen), result-
ing in pbbk17. The 1.8 kb bbk17 DNA fragment was removed
from pbbk17 by inverse PCR using the Expand Long PCR
system (Roche) and primers 7 and 8 (Table S2), yielding
linear pDbbk17 with SalI sites at its ends. The kanamycin
resistance cassette, ﬂgBp-kan (Bono et al., 2000), was ampli-
ﬁed from pBSV2 (Stewart et al., 2001) with XhoI ends using
primers 9 and 10 (Table S2). The ﬂgBp-kan cassette was
digested with XhoI and ligated into SalI cut-pDbbk17, yielding
pDbbk17::kan.2 0mgo fp Dbbk17::kan plasmid DNA puriﬁed
from E. coli was transformed into A3-M9 as previously
described (Samuels, 1995; Elias et al., 2002; Grimm et al.,
2004) and the recombinants were selected in solid BSK
medium containing kanamycin. Colonies were screened by
PCR for the presence of the kanamycin resistance cassette
in place of the bbk17 gene using primers 7 and 8 (Table S2).
Total genomic DNA was prepared from PCR-positive A3-M9
Dbbk17::ﬂgBp-kan clones and screened with a panel of
primers for the presence of all B. burgdorferi plasmids (Elias
et al., 2002). A clone that retained the B. burgdorferi plasmid
content of the parent clone was used in further experiments
(Table 1).
Construction of pBSV2G bbk17
The bbk17::ﬂgBp-kan mutant was complemented with
pBSV2G bbk17, a shuttle vector carrying a wild-type copy of
the bbk17 gene and its own promoter. This plasmid was also
used to reintroduce bbk17 alone to the A3-M9 lp36-minus
clone. Plasmid pBSV2G bbk17 was constructed by PCR-
amplifying a 1.8 kb DNA fragment containing the bbk17 gene
and its putative promoter region from strain B31 clone A3
using Vent polymerase (Invitrogen) and primers 11 and 12
(Table S2). The bbk17 gene was digested with KpnI and
BamHI and directionally cloned into the B. burgdorferi shuttle
vector pBSV2G (Elias et al., 2003) digested with KpnI and
BamHI. Plasmid structure and wild-type sequence were
analysed and veriﬁed by PCR with primers 11 and 12
(Table S2), restriction digestion and sequence analysis. To
facilitate transformation of pBSV2G bkk17 into the low
passage infectious clone, the E. coli puriﬁed plasmid was ﬁrst
transformed into the high passage, non-infectious clone,
B31-A(Byram et al., 2004). B31-Alacks lp25 but retains lp56,
both of which carry restriction modiﬁcation systems (Lawrenz
et al., 2002; Kawabata et al., 2004). Puriﬁcation of pBSV2G
bbk17 from lp56
+ B31-A should result in partially modiﬁed
B. burgdorferi DNA that may be less likely to be targeted
for degradation upon transformation into the lp25
+, lp56
+
low passage infectious clone. B. burgdorferi clones A3-M9
Dbbk17::ﬂgBp-kan and A3-M9 lp36-minus were transformed
with pBSV2G bbk17 puriﬁed from B31-A or pBSV2G alone
puriﬁed from E. coli (Samuels, 1995; Elias et al., 2002;
Grimm et al., 2004). Transformants were screened by PCR
for the presence of the bbk17 and aacC1 genes, or the aacC1
gene alone using primer pairs 11 and 12 and 4 and 9
(Table S2). PCR-positive transformants were analysed for
plasmid content and clones that retained the plasmids found
in the parent clone were selected for further experiments
(Table 1).
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Borrelia burgdorferi clones were inoculated from frozen
stocks into 5 ml of BSK II medium containing the appropriate
antibiotic and grown to an approximate density of 1 ¥ 10
7
spirochetes ml
-1. Clones were subsequently diluted in tripli-
cate to 1 ¥ 10
5 spirochetes ml
-1 in 5 ml of BSK II containing
the appropriate antibiotic. Spirochete density was determined
every 24 h over 120–140 h using a Petroff-Hausser counting
chamber.
Experimental tick-mouse infectious cycle
The Rocky Mountain Laboratories (RML) is accredited by the
InternationalAssociation forAssessment andAccreditation of
Laboratory Animal Care. Protocols for all animal experiments
were prepared according to the guidelines of the National
Institutes of Health and approved by the RML’s Animal Care
and Use Committee. Two different strains of mice were used
in these experiments. Mice from an outbred colony of Swiss-
Webster mice maintained at RML represent a genetically
heterogeneous rodent population (called RML mice) and
C3H/HeN mice (Harlan Sprague-Dawley, Indianapolis, IN)
represent a uniform, inbred rodent population. Needle inocu-
lations of mice were performed by 80% intraperitoneal and
20% subcutaneous inoculation with a target dose of 5 ¥ 10
3
spirochetes per mouse, using three to nine mice per
B. burgdorferi strain, and were performed at least twice. The
number of spirochetes inoculated into mice was determined
using a Petroff-Hausser counting chamber and veriﬁed by
colony-forming unit (cfu) counts in solid BSK medium; 10–20
colonies per inoculum were screened by PCR for the pres-
ence of the virulence plasmids lp25 and lp28-1. Actual doses
were calculated by adjusting the target doses for the
observed spirochete densities determined from the colony
counts and percentages of spirochetes carrying lp25 and
lp28-1. Total plasmid contents of all in vivo inoculum cultures
were veriﬁed using a panel of primers that amplify speciﬁc
DNAtargets on all B. burgdorferi plasmids (Elias et al., 2002).
Mouse infection was assessed 3–7 weeks post inoculation by
immunoblot analysis of mouse sera and reisolation of spiro-
chetes from ear, bladder and joint tissues, as previously
described (Simpson et al., 1991; Elias et al., 2002; Grimm
et al., 2003; 2004). Fischer’s exact test was used to generate
a P-value for the test of no difference between the numbers
of mice infected with different B. burgdorferi clones. The
analysis was implemented using R software, version 2.2.1
(R Development Core Team, 2005).
Cohorts of 100–200 4-month-old I. scapularis tick larvae
(from a colony maintained at RML, Hamilton, MT) were
experimentally infected with equal density, exponential phase
cultures of various B. burgdorferi clones as previously
described (Policastro and Schwan, 2003; Grimm et al.,
2005). Each immersion was performed in duplicate and the
entire experiment performed at least twice. Infection of larvae
and nymphs (following the molt) were assessed 7–14 days
post feeding to repletion (100–200 larvae or 15–25 nymphs
were applied per mouse) by IFA (Schwan and Piesman,
2000) and spirochete density per tick quantiﬁed by plating of
dilutions of triturated whole ticks in solid BSK medium, as
previously described (Grimm et al., 2005). Infection of RML
mice fed on by infected ticks was assessed 3–9 weeks post
tick feeding by seroconversion to B. burgdorferi antigens
(Simpson et al., 1991; Elias et al., 2002; Grimm et al., 2003;
2004), reisolation of spirochetes from mouse tissues (Elias
et al., 2002; Grimm et al., 2004) and xenodiagnosis using
uninfected I. scapularis (RML) (Schwan and Piesman, 2000).
Fischer’s exact test was used to generate a P-value for the
test of no difference between the numbers of mice infected
with different B. burgdorferi clones. The analysis was imple-
mented using R software, version 2.2.1 (R Development
Core Team, 2005).
Determination of ID50
The dose required to infect half the of the mice inoculated
(ID50)wasexperimentallydeterminedforB. burgdorfericlones
A3-M9 lp36-minus, A3-M9 lp36-minus/lp36-gent, A3-M9
lp36-minus/pBSV2G bbk17, A3-M9 Dbbk17::ﬂgBp-kan/
pBSV2G and A3-M9 Dbbk17::ﬂgBp-kan/pBSV2G bbk17.
Groups of 2–6 C3H/HeN mice (Harlan Sprague-Dawley,
Indianapolis, IN) were inoculated with 10-fold increasing
doses of spirochetes estimated to ﬂank the ID50, as described
above. Target dose ranges for B. burgdorferi clones were
as follows: A3-M9 lp36-minus: 1 ¥ 10
4 - 1 ¥ 10
8; A3-M9
lp36-minus/lp36-gent: 1 ¥ 10
1 - 1 ¥ 10
8; A3-M9 lp36-minus/
pBSV2G bbk17:1¥ 10
2 - 1 ¥ 10
6; A3-M9 Dbbk17::ﬂgBp-kan/
pBSV2G: 1 ¥ 10
3 - 1 ¥ 10
7 and A3-M9 Dbbk17::ﬂgBp-kan/
pBSV2G bbk17:1 ¥ 10
2 - 1 ¥ 10
5. Actual doses were
calculated by adjusting the target doses for the observed
spirochete densities determined from the colony counts and
percentages of spirochetes carrying lp25 and lp28-1. Two
mice were inoculated with BSK II medium alone as negative
controls. Mouse infection was assessed 4-weeks post inocu-
lation as described above.
The data from the ID50 infection experiment and the single
dose infection experiment for each clone were combined for
the estimations of the 50% infectious dose. The ID50 value for
each clone was derived using probit regression with a sepa-
rate location parameter (intercept) for each clone to ﬁt clone-
speciﬁc curves to the proportions of mice infected versus the
log10(adjusted dose). This model assumed identical slopes for
the dose–response curve of each clone. With this parameter-
ization, the differences in infectivity between the different
clones can be seen as lateral shifts of the dose–response
curve along the dose axis (Fig. 4). The log10ID50 for each
Borrelia clone was derived by ﬁnding the place on its ﬁtted
curve that corresponds to the 50% infection mark and then
converting the log-dose value back to the original scale to
give the ID50 (Table S1). The model also ﬁtted an overdisper-
sion factor that adjusts the standard errors and widens the
conﬁdence intervals otherwise derived from the model. This
was needed to account for greater heterogeneity in the infec-
tion rates than explained by dose and Borrelia clone alone.
The analysis was implemented using R software, version
2.2.1 (R Development Core Team, 2005).
Quantitative assessment of spirochetal loads in mouse
tissues
Ear, heart and joint tissues were harvested from inoculated
mice at the time of sacriﬁce. Total mouse and spirochete DNA
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et al., 1995) using collagenase A (Roche, Indianapolis, IN),
proteinase K (Invitrogen), and DNase-free RNase (QIAGEN)
digestions, in combination with phenol-chloroform and
chloroform extractions and ethanol precipitations. DNA was
resuspended in 100 ml of DNase/RNase-free water and run
through a QIAquick PCR puriﬁcation column (QIAGEN). The
concentration of the puriﬁed DNA was measured at 260 nm
and diluted to 50 mgm l
-1 in DNase/RNase-free water. Real-
time PCR to quantify B. burgdorferi genomes with respect to
mouse genomes was performed with TaqMan primers and
probes (Sigma-Genosys) (Table S2) for the ﬂaB gene
(B. burgdorferi chromosome) (primers 13 and 14, probe 1)
and the mouse nidogen gene (Morrison et al., 1999) (primers
15 and 16, probe 2) using an Applied Biosystems 7900HT
instrument. Samples were analysed in triplicate and the spi-
rochete burden was expressed as ﬂaB spirochete DNA
copies per 1000 nid mouse DNA copies. Data sets were
compared using one-way ANOVA with Tukey’s post test using
GraphPad Prism version 4.00 for Windows (GraphPad Soft-
ware, San Diego California USA).
Adenine deaminase enzyme activity assay
Borrelia burgdorferi clones were grown in 250 ml of BSK II
medium containing the appropriate antibiotic(s) to an approxi-
mate density of 7 ¥ 10
7 cells ml
-1. Spirochetes were har-
vested by centrifugation and washed twice with 10 mM NaCl,
20 mM HEPES pH 7.6. Cell pellets were resuspended in 5 ml
of 50 mM Tris pH 7.5 and lysed by French press (Thermo-
Spectronic) at 14 000 psi for three passes. Lysates were
cleared by centifugation, aliquoted and stored at -20°C.
Five hundred microlitres of cell lysate were added to assay
mixture (1 ml ﬁnal) containing 40 mM Tris pH 7.5, 5 mM
MnCl2 and 0.3 mM adenine. Reactions were incubated at
37°C for 30 min. Two hundred and thirty microlitres were
removed from the reaction mixture, in duplicate, at time 0 and
30 min and heat inactivated at 95°C for 10 min. One set of
duplicates was treated with 1 ml of (0.03 U) xanthine oxidase
(EC 1.1.3.22, Sigma), incubated at 37°C for 30 min and heat
inactivated as described above. All samples were cleared by
centrifugation prior to HPLC analysis.
Hypoxanthine production was analysed using an Agilent
1100 Series HPLC system connected to a Supelco C18,
4.6 ¥ 150 mm reverse phase column (Sigma) protected with
a guard column of identical composition. One hundred
microlitres of samples were injected via the auto-sampler
onto the column equilibrated in and eluted isocratically with
500 mM potassium phosphate pH 4.0 and 2% methanol.
Absorbance during elution was monitored at 254 nm for
20 min. Peak identity was determined by retention time as
compared with authentic standards. In addition, the compo-
sition of the hypoxanthine peak was conﬁrmed by absence of
the peak following xanthine oxidase treatment. Peak area
was determined by integration and quantiﬁed against a cali-
bration curve prepared using 99% pure hypoxanthine
(Sigma). Adenine deaminase activity was calculated as the
rate of increase in hypoxanthine over 30 min. Protein con-
centrations were measured using the Bicinchoninic Acid
Protein Assay Kit (Sigma). Adenine deaminase activity is
presented as the picomoles of hypoxanthine produced per
minute per milligram of total protein in each lysate. Assays
were performed in triplicate and error is given as the standard
deviation from the mean.
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Table S1. Determination of ID50 of various B. burgdorferi
clones. Groups of C3H/HeN mice were inoculated with
10-fold increasing target doses of spirochetes. Mouse infec-
tion was assessed 4-weeks post inoculation by reisolation
of spirochetes from ear, bladder and joint tissues. The ID50
value for each clone was estimated using probit regression
with a separate location parameter (intercept) for each
clone to ﬁt clone-speciﬁc curves to the proportion of mice
infected versus the log10(adjusted dose) (Fig. 3). The
log10ID50 for each Borrelia clone was derived by ﬁnding the
place on its ﬁtted curve that corresponded to the 50% infec-
tion mark and then converting the log-dose back to the
original scale to give the ID50. 95% conﬁdence intervals for
each ID50 value are shown.
Table S2. Primers and TaqMan probes used in this study.
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